Lilly drug combo drives record weight loss in diabetes study
Eli Lilly said a drug combination produced record weight loss in a diabetes study.
Story updates
02:15:42 PM UTC
SquawkNews
LLY - Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes